Categories
Specials
Actemra 80 mg / 4 mL Injection ( Tocilizumab ) Vial for IV infusion
Product Code: 11182
Availability: Out Of Stock
Price: 1,335EGP
Ex Tax: 1,335EGP

Qty:

 
Add to Wish List Add to Compare
   0 reviews  |  Write a review

Example

Returns

You can return the product within 14 days of purchase.

Returns

You can return the product within 14 days of purchase.

Custom block

Actemra 80 mg Injection

Manufactured ByRoche India
ContainsTocilizumab
Description

Actemra 80 mg Injection belongs to a group of medicines called anti-rheumatic agents. It is used for the treatment of mild to moderate rheumatic arthritis (RA) and giant cell arteritis (GCA) in adults. It is also used for the treatment of Polyarticular juvenile idiopathic arthritis (PJIA), systemic juvenile idiopathic arthritis, and cytokine release syndrome in children aged two years and above. It may be used alone or in a combination with other medicines for the treatment of the above-mentioned diseases.

Side effects

Major & minor side effects for Actemra 80 mg Injection

  • Mild fever and chills
     
  • High blood pressure
     
  • Skin rash and itching
     
  • Headache
     
  • Flu like symptoms
     
     
  • Sore throat
     
  • Nausea and Vomiting
     
  •  Stomach pain
     
  • Constipation
     
  • Mouth blisters
     
  • Joint pain
     
     
  • Difficult and painful breathing
     
     
  • Severe light-headedness
     
     
  • Severe skin rash and hives
     
     
  • Black or tarry stools
     
     
     
  • Bloody or coffee colored vomit
     
     
  • Blurred vision
     
     
     
  • Bloody or cloudy urine
     
     
  • Change in heart rate 
     
     
  • Unusual bleeding or bruising
     
     
     
  • Loss of appetite
     
  • Injection site bruising and red coloration
     
  • Loss of consciousness
     
     
     
  • Skin blistering
     
  • Diarrhea
     

Uses of Actemra 80 mg Injection

What is it prescribed for?

  • Rheumatoid Arthritis
    This medicine is indicated for the treatment of rheumatoid arthritis, an immune disorder characterized by pain and swelling of joints. It is normally used when other disease-modifying anti-rheumatoid medications are not effective.
  • Giant cell arteritis
    This medicine is indicated for the treatment of giant cell arteritis, a condition where blood vessels, particularly in the head and scalp area, become swollen.
  • Polyarticular juvenile idiopathic arthritis
    This medicine is indicated for the treatment of polyarticular juvenile idiopathic arthritis, an arthritic condition in children characterized by swollen and painful joints. It should only be used in children aged 2 years or above.
  • Systemic juvenile idiopathic arthritis
    This medicine is indicated for the treatment of systemic juvenile idiopathic arthritis, an inflammatory condition causing fever, pain, swelling, and developmental abnormalities of different parts of the body in children aged 2 years and above.
  • Cytokine release syndrome
    This medicine is used for the treatment of cytokine release syndrome, a severe and life-threatening reaction that usually develops after receiving certain immunotherapy medications via infusion.
  • Concerns

    Commonly asked questions

    • Onset of action
       
      The amount of time required for this medicine to show its action is not clinically established.
    • Duration of effect
       
      The amount of time for which this medicine remains active in the body is not clinically established.
    • Safe with alcohol?
       
      Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
    • Is it habit forming?
       
      No habit-forming tendencies were reported.
    • Usage in pregnancy?
       
      This medicine is not recommended for use in pregnant women unless absolutely necessary. All the potential benefits and risks associated with use should be carefully evaluated. Your doctor may prescribe an alternative medicine based on your clinical condition.
    • Usage while breast-feeding?
       
      This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before using/receiving this medicine. Your doctor may advise you to discontinue the drug or to discontinue breastfeeding based on your clinical condition.

    •  

      Allergy

      This medicine is not recommended for use in patients with a known allergy to tocilizumab or any other inactive ingredients present along in the formulation. It is also not recommended for use if you have a history of allergy to any other recombinant human or humanized antibodies or proteins that are of hamster origin.

      Active severe infection

      This medicine is not recommended for use in patients suffering from an active severe infection due to the increased risk of worsening of the patient's condition.

    • Warnings for special population
       

      Pregnancy

      This medicine is not recommended for use in pregnant women unless absolutely necessary. All the potential benefits and risks associated with use should be carefully evaluated. Your doctor may prescribe an alternative medicine based on your clinical condition.

      Breast-feeding

      This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before using/receiving this medicine. Your doctor may advise you to discontinue the drug or to discontinue breastfeeding based on your clinical condition.
      General warnings
       

      Low blood cell counts

      This medicine is not recommended for use in patients with lower values of absolute neutrophil count and platelet counts. Monitoring of these levels is necessary every 4-8 weeks while receiving this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition of the patient.

      Elevated liver enzymes

      This medicine is not recommended for use in patients with ALT and AST levels more than 1.5 times of the upper limit of normal. Monitoring of these levels is necessary every 4-8 weeks while receiving this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition of the patient.

      Lipid abnormalities

      This medicine is not recommended for use in patients with higher levels of triglycerides or cholesterol. Monitoring of these levels is necessary every 4-8 weeks while receiving this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition of the patient.

      Immune suppression

      Usage of this medicine weakens your immune system, thereby increasing the chances of opportunistic infections. Suitable preventive measures should be adopted to avoid such infections.

      Vaccinations

      Vaccinations with live or attenuated strains of micro-organisms should be avoided while taking this medicine due to the increased risk of worsening of the patient’s condition. Similarly, treatment with this medicine should not be initiated if the patient has been vaccinated recently.

      Other medicines

      Actemra 80 mg Injection may interact with many other medicines and may cause severe adverse effects. Hence, it is advised that you inform the doctor about all your current medicines including any herbs and supplements before beginning treatment with this medicine.

      Heart diseases&a

      Write a review

      Your Name:


      Your Review: Note: HTML is not translated!

      Rating: Bad           Good

      Enter the code in the box below:



      Continue
      Related Products (3)


About us

we are community pharmacy located in cairo-egypt.
our telephon: 01008554699-26716563

Contact us

Facebook

Information

Customer Service

Extras

My Account

  • omar shalaby
Powered by Dr.Omar Shalaby Pharmacy +202 26716563 / +201008554699